Injective (INJ) is among the top-performing altcoins on Monday as bullish sentiment sweeps the cryptocurrency market.
The token is trading above $13.60, supported by renewed investor confidence following Bitcoin’s sharp rise above $105,000.
With macroeconomic optimism and regulatory progress driving broader market momentum, analysts suggest Bitcoin could challenge new all-time highs in the near term.
That backdrop is encouraging capital rotation into altcoins, and projects like Injective are benefiting from increased speculative interest.
Injective, a layer-1 blockchain focused on decentralized finance and real-world asset tokenization, continues to draw attention as narratives about scalability and use-case-driven growth gain traction.
Injective price extends gains above $10
The price of Injective (INJ) rose about 7% over the past 24 hours and is gaining as major altcoins such as Ethereum, BNB and Solana consolidate around key levels.
INJ jumped sharply after recently surpassing the $10 mark.
It is currently changing hands around $13.62. On May 12, 2025, the token reached a high of $14.29, the highest level since late February.
Amid price gains, Injective’s market capitalization climbed to $1.37 billion, although 24‑hour trading volume remained modest at $172 million.
Having gained 46% over seven days and 67% over the past 30 days, overall market interest suggests bulls may be taking control.
Bitcoin rally and RWA tokenization drive INJ price
Alongside Bitcoin’s rally that has sparked broader market optimism, strong institutional demand across the real-world asset (RWA) ecosystem is another key driver of INJ price.
Tokenization is an important tailwind for Injective, with recent industry commentary highlighting how this sector is providing traction for INJ.
In previous bull cycles, DeFi, play-to-earn gaming, memecoins and AI tokens saw explosive growth.
Analysts now argue that while those areas continue to expand, the rise of the RWA market is putting blockchains like Injective in the spotlight.
The Injective network, optimized for tokenizing traditional assets such as equities, stablecoins and commodities, is well positioned to benefit.
Investors seeking on-chain exposure to real-world assets increasingly view Injective as a platform to watch.
Broader adoption of RWA tokenization could further amplify INJ’s price momentum.
Injective price technical outlook
From a technical perspective, the daily chart for INJ paints a bullish picture.
INJ chart from TradingView
The daily Relative Strength Index (RSI) currently sits in overbought territory.
However, it is not extended enough to rule out further upside for bulls.
In the event of a pullback, INJ is likely to find support around $11.05 and $10.22.
This outlook aligns with the moving average convergence divergence (MACD), which is showing a bullish crossover.
The histogram indicates rising momentum. If momentum continues, bulls will likely target $16 and then $20.